These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
406 related articles for article (PubMed ID: 34935421)
1. Expanding the Colorectal Cancer Biomarkers Based on the Human Gut Phageome. Shen S; Huo D; Ma C; Jiang S; Zhang J Microbiol Spectr; 2021 Dec; 9(3):e0009021. PubMed ID: 34935421 [TBL] [Abstract][Full Text] [Related]
2. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Yu J; Feng Q; Wong SH; Zhang D; Liang QY; Qin Y; Tang L; Zhao H; Stenvang J; Li Y; Wang X; Xu X; Chen N; Wu WK; Al-Aama J; Nielsen HJ; Kiilerich P; Jensen BA; Yau TO; Lan Z; Jia H; Li J; Xiao L; Lam TY; Ng SC; Cheng AS; Wong VW; Chan FK; Xu X; Yang H; Madsen L; Datz C; Tilg H; Wang J; BrĂ¼nner N; Kristiansen K; Arumugam M; Sung JJ; Wang J Gut; 2017 Jan; 66(1):70-78. PubMed ID: 26408641 [TBL] [Abstract][Full Text] [Related]
3. Alterations in Enteric Virome Are Associated With Colorectal Cancer and Survival Outcomes. Nakatsu G; Zhou H; Wu WKK; Wong SH; Coker OO; Dai Z; Li X; Szeto CH; Sugimura N; Lam TY; Yu AC; Wang X; Chen Z; Wong MC; Ng SC; Chan MTV; Chan PKS; Chan FKL; Sung JJ; Yu J Gastroenterology; 2018 Aug; 155(2):529-541.e5. PubMed ID: 29689266 [TBL] [Abstract][Full Text] [Related]
4. Whole-Virome Analysis Sheds Light on Viral Dark Matter in Inflammatory Bowel Disease. Clooney AG; Sutton TDS; Shkoporov AN; Holohan RK; Daly KM; O'Regan O; Ryan FJ; Draper LA; Plevy SE; Ross RP; Hill C Cell Host Microbe; 2019 Dec; 26(6):764-778.e5. PubMed ID: 31757768 [TBL] [Abstract][Full Text] [Related]
5. Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers. Dai Z; Coker OO; Nakatsu G; Wu WKK; Zhao L; Chen Z; Chan FKL; Kristiansen K; Sung JJY; Wong SH; Yu J Microbiome; 2018 Apr; 6(1):70. PubMed ID: 29642940 [TBL] [Abstract][Full Text] [Related]
6. Metagenomic Analyses Expand Bacterial and Functional Profiling Biomarkers for Colorectal Cancer in a Hainan Cohort, China. Chang H; Mishra R; Cen C; Tang Y; Ma C; Wasti S; Wang Y; Ou Q; Chen K; Zhang J Curr Microbiol; 2021 Feb; 78(2):705-712. PubMed ID: 33410957 [TBL] [Abstract][Full Text] [Related]
7. Gut virome-wide association analysis identifies cross-population viral signatures for inflammatory bowel disease. Tian X; Li S; Wang C; Zhang Y; Feng X; Yan Q; Guo R; Wu F; Wu C; Wang Y; Huo X; Ma X Microbiome; 2024 Jul; 12(1):130. PubMed ID: 39026313 [TBL] [Abstract][Full Text] [Related]
8. Bacteriophages in the human gut: Our fellow travelers throughout life and potential biomarkers of heath or disease. Bakhshinejad B; Ghiasvand S Virus Res; 2017 Aug; 240():47-55. PubMed ID: 28743462 [TBL] [Abstract][Full Text] [Related]
9. Reproducible protocols for metagenomic analysis of human faecal phageomes. Shkoporov AN; Ryan FJ; Draper LA; Forde A; Stockdale SR; Daly KM; McDonnell SA; Nolan JA; Sutton TDS; Dalmasso M; McCann A; Ross RP; Hill C Microbiome; 2018 Apr; 6(1):68. PubMed ID: 29631623 [TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of fecal viromes demonstrates high diagnostic potential of the gut viral signatures for colorectal cancer and adenoma risk assessment. Chen F; Li S; Guo R; Song F; Zhang Y; Wang X; Huo X; Lv Q; Ullah H; Wang G; Ma Y; Yan Q; Ma X J Adv Res; 2023 Jul; 49():103-114. PubMed ID: 36198381 [TBL] [Abstract][Full Text] [Related]
11. Establishing a novel colorectal cancer predictive model based on unique gut microbial single nucleotide variant markers. Ma C; Chen K; Wang Y; Cen C; Zhai Q; Zhang J Gut Microbes; 2021; 13(1):1-6. PubMed ID: 33430705 [TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer and gut microbiota studies in China. Wang Z; Dan W; Zhang N; Fang J; Yang Y Gut Microbes; 2023; 15(1):2236364. PubMed ID: 37482657 [TBL] [Abstract][Full Text] [Related]
13. Disease-specific alterations in the enteric virome in inflammatory bowel disease. Norman JM; Handley SA; Baldridge MT; Droit L; Liu CY; Keller BC; Kambal A; Monaco CL; Zhao G; Fleshner P; Stappenbeck TS; McGovern DP; Keshavarzian A; Mutlu EA; Sauk J; Gevers D; Xavier RJ; Wang D; Parkes M; Virgin HW Cell; 2015 Jan; 160(3):447-60. PubMed ID: 25619688 [TBL] [Abstract][Full Text] [Related]
14. Metagenomic Analyses of Multiple Gut Datasets Revealed the Association of Phage Signatures in Colorectal Cancer. Zuo W; Michail S; Sun F Front Cell Infect Microbiol; 2022; 12():918010. PubMed ID: 35782128 [TBL] [Abstract][Full Text] [Related]
15. A human gut phage catalog correlates the gut phageome with type 2 diabetes. Ma Y; You X; Mai G; Tokuyasu T; Liu C Microbiome; 2018 Feb; 6(1):24. PubMed ID: 29391057 [TBL] [Abstract][Full Text] [Related]
16. Parvimonas micra, Peptostreptococcus stomatis, Fusobacterium nucleatum and Akkermansia muciniphila as a four-bacteria biomarker panel of colorectal cancer. Osman MA; Neoh HM; Ab Mutalib NS; Chin SF; Mazlan L; Raja Ali RA; Zakaria AD; Ngiu CS; Ang MY; Jamal R Sci Rep; 2021 Feb; 11(1):2925. PubMed ID: 33536501 [TBL] [Abstract][Full Text] [Related]
17. The phageome of patients with ulcerative colitis treated with donor fecal microbiota reveals markers associated with disease remission. Majzoub ME; Paramsothy S; Haifer C; Parthasarathy R; Borody TJ; Leong RW; Kamm MA; Kaakoush NO Nat Commun; 2024 Oct; 15(1):8979. PubMed ID: 39420033 [TBL] [Abstract][Full Text] [Related]
18. Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis. Huang X; Hong X; Wang J; Sun T; Yu T; Yu Y; Fang J; Xiong H EBioMedicine; 2020 Nov; 61():103037. PubMed ID: 33039709 [TBL] [Abstract][Full Text] [Related]
19. Southern Chinese populations harbour non-nucleatum Fusobacteria possessing homologues of the colorectal cancer-associated FadA virulence factor. Yeoh YK; Chen Z; Wong MCS; Hui M; Yu J; Ng SC; Sung JJY; Chan FKL; Chan PKS Gut; 2020 Nov; 69(11):1998-2007. PubMed ID: 32051205 [TBL] [Abstract][Full Text] [Related]
20. Gut phageome in Mexican Americans: a population at high risk for metabolic dysfunction-associated steatotic liver disease and diabetes. Kwan S-Y; Sabotta CM; Cruz LR; Wong MC; Ajami NJ; McCormick JB; Fisher-Hoch SP; Beretta L mSystems; 2024 Sep; 9(9):e0043424. PubMed ID: 39166873 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]